ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IDD Innate Pharma

2.13
0.075 (3.65%)
22 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Innate Pharma TG:IDD Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 3.65% 2.13 2.13 2.17 2.06 2.06 2.06 20 22:50:06

Directorate Change

07/10/2003 12:30pm

UK Regulatory


RNS Number:6068Q
ID Data PLC
07 October 2003

Press Release                                                     7 October 2003

                                  ID Data plc

                                 Board change

ID Data plc announces that Paul Knight has now stepped down from the Board today
in order to pursue academic interests.

Peter Cox, Chief Executive of ID Data, said: "The Board would like to thank Paul
for his significant contributions, particularly in founding TTi, our joint
venture business with Toshiba and Toppan.  We wish him all the best with his
future activities."

                                    - Ends -


For further information, please contact:
ID Data plc
Peter Cox, Chief Executive                             Tel: +44 (0) 1536 207 000
enquiries@id-data.co.uk

Media Enquiries:
Bankside
Heather Salmond                                        Tel: +44 (0) 20 7444 4148
heather.salmond@bankside.com

Notes to Editors:

ID Data plc ("ID Data") is the world's seventh-largest supplier of
secure-transaction systems and smart-card services to the international
telephony, banking, retail, and secure-access sectors.  The Company's strategy,
to move from commodity products to value-added services and solutions, has
created a solid platform on which to build further growth.  The Company's
clients include Vodafone, Nectar, Tesco, and Exxon Mobil.  ID Data has formed
agreements with major global corporations to facilitate rapid market development
including partnerships with Toshiba and Toppan.  The Company has delivered in
excess of 10 million chip cards to the banking market in the UK, giving it an
estimated 33% market share after less than 18 months.  The Company was founded
in 1988 and was listed on the AIM in October 2000.  The Company is certified to
the revised quality standard ISO9001: 2000.

www.id-data.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAEAFEXEAADFFE

1 Year Innate Pharma Chart

1 Year Innate Pharma Chart

1 Month Innate Pharma Chart

1 Month Innate Pharma Chart

Your Recent History

Delayed Upgrade Clock